FDA grants priority review to Tivicay PD for neonatal HIV
|
The Children with HIV Early Antiretroviral Therapy
(CHER) trial demonstrated that immediate ART initiation in HIV-infected
newborns reduced early ... |
Misinformation threatens rollout of HIV prevention drug lenacapavir
Health experts say false claims about the lenacapavir injection could undermine efforts to reduce new HIV infections in South Africa. View article...